Comparative studies of inhaled corticosteroids in asthma.
暂无分享,去创建一个
[1] L. Edwards,et al. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma. , 2000, The Journal of allergy and clinical immunology.
[2] R. Hubbard,et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma , 2000, The Lancet.
[3] B. Lipworth,et al. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. , 2000, The American journal of medicine.
[4] W. Lumry,et al. Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma , 2000 .
[5] D. Hendrick,et al. Effect of inhaled fluticasone propionate on airway responsiveness in treatment-naive individuals--a lesser benefit in females. , 2000, The European respiratory journal.
[6] J. Fahy,et al. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment. , 2000, The European respiratory journal.
[7] W. Busse,et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. , 1999, The Journal of allergy and clinical immunology.
[8] J. Vandenbroucke,et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.
[9] V. Backer,et al. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. , 1999, Canadian respiratory journal.
[10] S. Szefler,et al. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. , 1998, The Journal of pediatrics.
[11] T L Petty,et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. , 1998, The Journal of allergy and clinical immunology.
[12] W. Busse,et al. Efficacy and safety of inhaled corticosteroids. New developments. , 1998, American journal of respiratory and critical care medicine.
[13] D. Postma,et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. , 1997, The New England journal of medicine.
[14] S. Pedersen,et al. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. , 1997, The Journal of allergy and clinical immunology.
[15] B. Lipworth,et al. Dose-Response of Inhaled Drugs in Asthma , 1997, Clinical pharmacokinetics.
[16] F. Hampel,et al. Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study. , 1996, Clinical therapeutics.
[17] Tari Haahtela,et al. Randomised comparison of guided self management and traditional treatment of asthma over one year , 1996, BMJ.
[18] A Pietinalho,et al. Effect of early vs late intervention with inhaled corticosteroids in asthma. , 1995, Chest.
[19] R. Dockhorn,et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group. , 1994, The Journal of allergy and clinical immunology.
[20] T. Haahtela,et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. , 1994, The New England journal of medicine.
[21] L. Boulet,et al. Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma. , 1994, Chest.
[22] C. G. Langdon,et al. Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma. , 1994, Respiratory medicine.
[23] P. Howarth,et al. Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. , 1994, American journal of respiratory and critical care medicine.
[24] R. Dahl,et al. A Dose-Ranging Study of Fluticasone Propionate in Adult Patients With Moderate Asthma , 1993 .
[25] L. Lehtonen,et al. Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma , 1992, The Lancet.
[26] T. Haahtela,et al. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. , 1992, The Journal of allergy and clinical immunology.
[27] R. Dahl,et al. A double‐blind dose‐response study of budesonide by inhalation in patients with bronchial asthma , 1988, Allergy.
[28] K. Palmer,et al. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. , 1973, Lancet.